Basso Stephen 4
4 · Inozyme Pharma, Inc. · Filed Mar 25, 2021
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2021-03-24+13,000→ 13,000 totalExercise: $17.77Exp: 2031-03-23→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 24, 2021. The shares underlying the option are scheduled to vest in equal monthly installments through March 24, 2023.